• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

一种双受体靶向和 BBB 穿透肽功能化聚乙烯亚胺纳米复合物，用于将分泌型内皮抑素基因递送至恶性脑胶质瘤。

A Dual Receptor Targeting- and BBB Penetrating- Peptide Functionalized Polyethyleneimine Nanocomplex for Secretory Endostatin Gene Delivery to Malignant Glioma.

机构信息

Key Laboratory of Chemical Biology (Ministry of Education), Institute of Biochemical and Biotechnological Drug, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China.

Department of General Surgery, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China.

出版信息

Int J Nanomedicine. 2020 Nov 12;15:8875-8892. doi: 10.2147/IJN.S270208. eCollection 2020.

DOI:10.2147/IJN.S270208
PMID:33209022
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7669533/
Abstract

PURPOSE

Vascular endothelial growth factor receptor 2 (VEGFR-2) and neuropilin-1 (NRP-1) are two prominent synergistic receptors overexpressed on new blood vessels in glioma and may be promising targets for antiglioma therapy. The aim of this study was to design a dual receptor targeting and blood-brain barrier (BBB) penetrating peptide-modified polyethyleneimine (PEI) nanocomplex that can efficiently deliver the angiogenesis-inhibiting secretory endostatin gene (pVAXI-En) to treat glioma.

MATERIALS AND METHODS

We first constructed the tandem peptide TAT-AT7 by conjugating AT7 to TAT and evaluated its binding affinity to VEGFR-2 and NRP-1, vasculature-targeting ability and BBB crossing capacity. Then, TAT-AT7-modified PEI polymer (PPTA) was synthesized, and a pVAXI-En-loaded PPTA nanocomplex (PPTA/pVAXI-En) was prepared. The physicochemical properties, cytotoxicity, transfection efficiency, capacities to cross the BBB and BTB (blood-tumor barrier) and glioma-targeting properties of PPTA/pVAXI-En were investigated. Moreover, the in vivo anti-angiogenic behaviors and anti-glioma effects of PPTA/pVAXI-En were evaluated in nude mice.

RESULTS

The binding affinity of TAT-AT7 to VEGFR-2 and NRP-1 was approximately 3 to 10 times greater than that of AT7 or TAT. The cellular uptake of TAT-AT7 in endothelial cells was 5-fold and 119-fold greater than that of TAT and AT7 alone, respectively. TAT-AT7 also displayed remarkable efficiency in penetrating the BBB and glioma tissue in vivo. PPTA/pVAXI-En exhibited lower cytotoxicity, stronger BBB and BTB traversing abilities, higher selective glioma targeting and better gene transfection efficiency than PEI/pVAXI-En. More importantly, PPTA/pVAXI-En significantly suppressed the tube formation and migration of endothelial cells, inhibited glioma growth, and reduced the microvasculature in orthotopic U87 glioma-bearing nude mice.

CONCLUSION

Our study demonstrates that PPTA/pVAXI-En can be exploited as an efficient dual-targeting nanocomplex to cross the BBB and BTB, and hence it represents a feasible and promising nonviral gene delivery system for effective glioma therapy.

摘要

目的

血管内皮生长因子受体 2（VEGFR-2）和神经纤毛蛋白 1（NRP-1）是胶质瘤新生血管中过度表达的两个重要协同受体，可能是抗胶质瘤治疗的有前途的靶点。本研究旨在设计一种双受体靶向和血脑屏障（BBB）穿透肽修饰的聚乙烯亚胺（PEI）纳米复合物，可有效递送达血管生成抑制的分泌型内皮抑素基因（pVAXI-En），用于治疗脑胶质瘤。

材料与方法

我们首先通过将 AT7 缀合到 TAT 上来构建串联肽 TAT-AT7，并评估其与 VEGFR-2 和 NRP-1 的结合亲和力、血管靶向能力和 BBB 穿透能力。然后，合成 TAT-AT7 修饰的 PEI 聚合物（PPTA），并制备 pVAXI-En 负载的 PPTA 纳米复合物（PPTA/pVAXI-En）。研究了 PPTA/pVAXI-En 的理化性质、细胞毒性、转染效率、穿透 BBB 和 BTB（血肿瘤屏障）以及靶向胶质瘤的能力。此外，在裸鼠中评估了 PPTA/pVAXI-En 的体内抗血管生成作用和抗胶质瘤作用。

结果

TAT-AT7 与 VEGFR-2 和 NRP-1 的结合亲和力分别比 AT7 或 TAT 高约 3 至 10 倍。TAT-AT7 在血管内皮细胞中的摄取量分别比 TAT 和 AT7 单独增加了 5 倍和 119 倍。TAT-AT7 还在体内显示出穿透 BBB 和脑胶质瘤组织的显著效率。与 PEI/pVAXI-En 相比，PPTA/pVAXI-En 具有更低的细胞毒性、更强的 BBB 和 BTB 穿透能力、更高的选择性脑胶质瘤靶向性和更好的基因转染效率。更重要的是，PPTA/pVAXI-En 显著抑制了内皮细胞的管形成和迁移，抑制了脑胶质瘤的生长，并减少了荷 U87 脑胶质瘤裸鼠的微血管。

结论

我们的研究表明，PPTA/pVAXI-En 可被用作有效的双靶纳米复合物，以穿透 BBB 和 BTB，因此它代表了一种可行且有前途的非病毒基因传递系统，可有效治疗脑胶质瘤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa25/7669533/536dd12f4c1a/IJN-15-8875-g0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa25/7669533/87a1a800c7af/IJN-15-8875-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa25/7669533/d2aafc14d215/IJN-15-8875-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa25/7669533/23e27daad8a8/IJN-15-8875-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa25/7669533/e3d4289e20e4/IJN-15-8875-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa25/7669533/91be11a09a94/IJN-15-8875-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa25/7669533/9753ed7148b5/IJN-15-8875-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa25/7669533/fc397da5a582/IJN-15-8875-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa25/7669533/fbea52343e71/IJN-15-8875-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa25/7669533/93216335d65a/IJN-15-8875-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa25/7669533/536dd12f4c1a/IJN-15-8875-g0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa25/7669533/87a1a800c7af/IJN-15-8875-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa25/7669533/d2aafc14d215/IJN-15-8875-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa25/7669533/23e27daad8a8/IJN-15-8875-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa25/7669533/e3d4289e20e4/IJN-15-8875-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa25/7669533/91be11a09a94/IJN-15-8875-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa25/7669533/9753ed7148b5/IJN-15-8875-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa25/7669533/fc397da5a582/IJN-15-8875-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa25/7669533/fbea52343e71/IJN-15-8875-g0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa25/7669533/93216335d65a/IJN-15-8875-g0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa25/7669533/536dd12f4c1a/IJN-15-8875-g0010.jpg

相似文献

1
A Dual Receptor Targeting- and BBB Penetrating- Peptide Functionalized Polyethyleneimine Nanocomplex for Secretory Endostatin Gene Delivery to Malignant Glioma.一种双受体靶向和 BBB 穿透肽功能化聚乙烯亚胺纳米复合物，用于将分泌型内皮抑素基因递送至恶性脑胶质瘤。
Int J Nanomedicine. 2020 Nov 12;15:8875-8892. doi: 10.2147/IJN.S270208. eCollection 2020.
2
A Novel Blood-Brain Barrier-Penetrating and Vascular-Targeting Chimeric Peptide Inhibits Glioma Angiogenesis.一种新型血脑屏障穿透和血管靶向嵌合肽抑制胶质瘤血管生成。
Int J Mol Sci. 2023 May 15;24(10):8753. doi: 10.3390/ijms24108753.
3
Design and screening of a novel neuropilin-1 targeted penetrating peptide for anti-angiogenic therapy in glioma.设计和筛选一种新型的神经纤毛蛋白-1 靶向穿透肽用于神经胶质瘤的抗血管生成治疗。
Life Sci. 2021 Apr 1;270:119113. doi: 10.1016/j.lfs.2021.119113. Epub 2021 Jan 27.
4
Antitumoral Cascade-Targeting Ligand for IL-6 Receptor-Mediated Gene Delivery to Glioma.用于白细胞介素-6受体介导的基因递送至胶质瘤的抗肿瘤级联靶向配体
Mol Ther. 2017 Jul 5;25(7):1556-1566. doi: 10.1016/j.ymthe.2017.04.023. Epub 2017 May 11.
5
A non-viral suicide gene delivery system traversing the blood brain barrier for non-invasive glioma targeting treatment.一种穿越血脑屏障的非病毒自杀基因递药系统，用于非侵入性脑胶质瘤靶向治疗。
J Control Release. 2016 Dec 10;243:357-369. doi: 10.1016/j.jconrel.2016.10.027. Epub 2016 Oct 26.
6
T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting.利用 RNA 干扰技术的 T7 肽功能化纳米颗粒实现脑胶质瘤双重靶向
Int J Pharm. 2013 Sep 15;454(1):11-20. doi: 10.1016/j.ijpharm.2013.07.019. Epub 2013 Jul 15.
7
NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo.NRP-1 靶向载药外泌体促进胶质瘤的体内外同步成像和治疗。
Biomaterials. 2018 Sep;178:302-316. doi: 10.1016/j.biomaterials.2018.06.029. Epub 2018 Jun 21.
8
Polyethylenimine-based theranostic nanoplatform for glioma-targeting single-photon emission computed tomography imaging and anticancer drug delivery.基于聚亚乙基亚胺的诊疗一体化纳米平台用于脑胶质瘤靶向单光子发射计算机断层成像和抗癌药物递送。
J Nanobiotechnology. 2020 Oct 14;18(1):143. doi: 10.1186/s12951-020-00705-3.
9
Highly efficacious and specific anti-glioma chemotherapy by tandem nanomicelles co-functionalized with brain tumor-targeting and cell-penetrating peptides.通过串联纳米胶束共功能化脑肿瘤靶向和细胞穿透肽实现高效和特异性抗神经胶质瘤化疗。
J Control Release. 2018 May 28;278:1-8. doi: 10.1016/j.jconrel.2018.03.025. Epub 2018 Mar 27.
10
Retro-inverso CendR peptide-mediated polyethyleneimine for intracranial glioblastoma-targeting gene therapy.反义 CendR 肽介导的聚乙烯亚胺用于颅内神经胶质瘤靶向基因治疗。
Bioconjug Chem. 2014 Feb 19;25(2):414-23. doi: 10.1021/bc400552t. Epub 2014 Feb 7.

引用本文的文献

1
Cell-penetrating peptides as facilitators of cargo-specific nanocarrier-based drug delivery.细胞穿透肽作为基于纳米载体的货物特异性药物递送的促进剂。
Nanoscale. 2025 Aug 26. doi: 10.1039/d5nr00617a.
2
Multiscale analysis and optimal glioma therapeutic candidate discovery using the CANDO platform.使用CANDO平台进行多尺度分析和最佳胶质瘤治疗候选物发现。
bioRxiv. 2025 May 23:2025.05.19.654757. doi: 10.1101/2025.05.19.654757.
3
Peptide-Functionalized Nanomedicine: Advancements in Drug Delivery, Diagnostics, and Biomedical Applications.

本文引用的文献

1
The influx/efflux mechanisms of d-peptide ligand of nAChRs across the blood-brain barrier and its therapeutic value in treating glioma.烟碱型乙酰胆碱受体的 D-肽配体通过血脑屏障的内外流机制及其在治疗神经胶质瘤中的治疗价值。
J Control Release. 2020 Nov 10;327:384-396. doi: 10.1016/j.jconrel.2020.08.010. Epub 2020 Aug 11.
2
Autophagy inhibition changes the disposition of non-viral gene carriers during blood-brain barrier penetration and enhances TRAIL-induced apoptosis in brain metastatic tumor.自噬抑制改变了血脑屏障穿透过程中非病毒基因载体的分布，并增强了脑转移瘤中 TRAIL 诱导的细胞凋亡。
J Control Release. 2020 May 10;321:497-508. doi: 10.1016/j.jconrel.2020.02.042. Epub 2020 Feb 26.
3
肽功能化纳米药物：药物递送、诊断及生物医学应用的进展
Molecules. 2025 Mar 31;30(7):1572. doi: 10.3390/molecules30071572.
4
Nanotherapeutic Formulations for the Delivery of Cancer Antiangiogenics.用于递送癌症抗血管生成药物的纳米治疗制剂
Mol Pharm. 2025 May 5;22(5):2322-2349. doi: 10.1021/acs.molpharmaceut.4c00822. Epub 2025 Apr 4.
5
Towards a New Dawn for Neuro-Oncology: Nanomedicine at the Service of Drug Delivery for Primary and Secondary Brain Tumours.迈向神经肿瘤学的新曙光：纳米医学助力原发性和继发性脑肿瘤的药物递送
Brain Sci. 2025 Jan 30;15(2):136. doi: 10.3390/brainsci15020136.
6
Targeting Brain Drug Delivery with Macromolecules Through Receptor-Mediated Transcytosis.通过受体介导的转胞吞作用利用大分子靶向脑药物递送。
Pharmaceutics. 2025 Jan 15;17(1):109. doi: 10.3390/pharmaceutics17010109.
7
Drug Delivery Across the Blood-Brain Barrier: A New Strategy for the Treatment of Neurological Diseases.药物透过血脑屏障的递送：治疗神经疾病的新策略。
Pharmaceutics. 2024 Dec 19;16(12):1611. doi: 10.3390/pharmaceutics16121611.
8
Liposomal Nanomaterials: A Rising Star in Glioma Treatment.脂质体纳米材料：脑胶质瘤治疗的后起之秀。
Int J Nanomedicine. 2024 Jul 5;19:6757-6776. doi: 10.2147/IJN.S470478. eCollection 2024.
9
Progress of nanoparticle drug delivery system for the treatment of glioma.用于治疗神经胶质瘤的纳米颗粒药物递送系统的进展
Front Bioeng Biotechnol. 2024 Jun 11;12:1403511. doi: 10.3389/fbioe.2024.1403511. eCollection 2024.
10
A receptor-mediated landscape of druggable and targeted nanomaterials for gliomas.用于神经胶质瘤的可药物化和靶向纳米材料的受体介导格局。
Mater Today Bio. 2023 May 19;20:100671. doi: 10.1016/j.mtbio.2023.100671. eCollection 2023 Jun.
Nanomaterial-based blood-brain-barrier (BBB) crossing strategies.
基于纳米材料的血脑屏障（BBB）穿越策略。
Biomaterials. 2019 Dec;224:119491. doi: 10.1016/j.biomaterials.2019.119491. Epub 2019 Sep 14.
4
Folate-modified carboxymethyl-chitosan/polyethylenimine/bovine serum albumin based complexes for tumor site-specific drug delivery.基于叶酸修饰的羧甲基壳聚糖/聚乙烯亚胺/牛血清白蛋白的复合物用于肿瘤部位特异性药物递送。
Carbohydr Polym. 2018 Oct 15;198:76-85. doi: 10.1016/j.carbpol.2018.06.055. Epub 2018 Jun 14.
5
A ternary-complex of a suicide gene, a RAGE-binding peptide, and polyethylenimine as a gene delivery system with anti-tumor and anti-angiogenic dual effects in glioblastoma.载自杀基因、RAGE 结合肽和聚乙烯亚胺的三元复合物作为基因传递系统在胶质母细胞瘤中具有抗肿瘤和抗血管生成的双重作用。
J Control Release. 2018 Jun 10;279:40-52. doi: 10.1016/j.jconrel.2018.04.021. Epub 2018 Apr 13.
6
Highly efficacious and specific anti-glioma chemotherapy by tandem nanomicelles co-functionalized with brain tumor-targeting and cell-penetrating peptides.通过串联纳米胶束共功能化脑肿瘤靶向和细胞穿透肽实现高效和特异性抗神经胶质瘤化疗。
J Control Release. 2018 May 28;278:1-8. doi: 10.1016/j.jconrel.2018.03.025. Epub 2018 Mar 27.
7
Overcoming obstacles in the tumor microenvironment: Recent advancements in nanoparticle delivery for cancer theranostics.克服肿瘤微环境中的障碍：用于癌症治疗与诊断的纳米颗粒递药的最新进展。
Biomaterials. 2018 Feb;156:217-237. doi: 10.1016/j.biomaterials.2017.10.024. Epub 2017 Oct 20.
8
Ligand-Targeted Drug Delivery.配体靶向药物递送。
Chem Rev. 2017 Oct 11;117(19):12133-12164. doi: 10.1021/acs.chemrev.7b00013. Epub 2017 Sep 12.
9
Nonviral cancer gene therapy: Delivery cascade and vector nanoproperty integration.非病毒癌症基因治疗：递药级联和载体纳米特性整合。
Adv Drug Deliv Rev. 2017 Jun 1;115:115-154. doi: 10.1016/j.addr.2017.07.021. Epub 2017 Aug 1.
10
Dual-modified liposome codelivery of doxorubicin and vincristine improve targeting and therapeutic efficacy of glioma.阿霉素和长春新碱的双修饰脂质体共递送可提高胶质瘤的靶向性和治疗效果。
Drug Deliv. 2017 Nov;24(1):1045-1055. doi: 10.1080/10717544.2017.1344334.